Position in MLTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$311,544,999
+$13,281,066 QoQ
Shares Held
16,001,284
0.0% QoQ
Ownership
18.8%
of shares outstanding
% of Portfolio
8.68%
of 13F equity value
Holder Rank
#1
of 171 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MLTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BVF INC/IL holds $3,440,293,274 across 41 Biotechnology names. MLTX ranks #3 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,965,160 | $555,315,164 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
3,872,052 | $444,008,202 | |
| 3 | MLTX |
MoonLake Immunotherapeutics
This page
|
16,001,284 | $311,544,999 | |
| 4 | GHRS |
GH Research PLC
|
8,650,158 | $232,516,247 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
3,366,823 | $180,697,390 | |
| 6 | NKTR |
Nektar Therapeutics
|
2,391,075 | $166,920,945 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,056,027 | $123,629,080 | |
| 8 | XNCR |
Xencor Inc
|
7,133,720 | $114,852,892 |
All Filings in MLTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $311,544,999 | 16,001,284 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $298,263,933 | 16,001,284 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $260,321,923 | 19,751,284 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $141,616,706 | 19,751,284 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $932,260,604 | 19,751,284 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $771,682,665 | 19,751,284 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,069,532,028 | 19,751,284 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,096,699,739 | 21,751,284 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $956,403,957 | 21,751,284 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,092,566,995 | 21,751,284 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,313,560,040 | 21,751,284 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,239,823,188 | 21,751,284 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,109,315,484 | 21,751,284 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $465,259,964 | 21,751,284 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $228,388,482 | 21,751,284 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $168,789,963 | 21,751,284 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $114,194,241 | 21,751,284 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||